MétaCan
Menu
← Back to cohort
Record W4385631697 · doi:10.1136/lupus-2023-kcr.124

LSO-083 ‘Systemic lupus erythematosus women with lupus nephritis in pregnancy therapeutic challenge (SWITCH)’: the systemic lupus international collaborating clinics experience

2023· article· en· W4385631697 on OpenAlexaff
Joo‐Young Lee, Arielle Mendel, Anca Askanase, Sang‐Cheol Bae, Jill P. Buyon, Ann E. Clarke, N. Costedoat‐Chalumeau, Paul R. Fortin, Dafna D. Gladman, Rosalind Ramsey‐Goldman, John G. Hanly, Murat İnanç, David Isenberg, Anselm Mak, Marta Mosca, Michelle Petri, Anisur Rahman, Jorge Sánchez‐Guerrero, Murray B. Urowitz, Daniel J. Wallace, Sasha Bernatsky, Évelyne Vinet

Bibliographic record

Venuenot available
Typearticle
Languageen
FieldMedicine
TopicPregnancy and Medication Impact
Canadian institutionsMount Sinai HospitalDalhousie UniversityUniversity of TorontoUniversity Health NetworkQueen Elizabeth II Health Sciences CentreUniversité LavalToronto Western HospitalCentre hospitalier universitaire de QuébecUniversity of CalgaryMcGill University Health Centre
Fundersnot available
KeywordsMedicineLupus nephritisPregnancyAzathioprineThiopurine methyltransferaseTacrolimusSystemic lupus erythematosusLive birthInternal medicineTransplantationDisease

Abstract

fetched live from OpenAlex

Background Many SLE patients develop lupus nephritis (LN) and receive mycophenolate mofetil (MMF), a teratogenic drug. Guidelines recommend azathioprine (AZA) in SLE pregnancy without providing guidance on pharmacogenetic testing and therapeutic monitoring although these may help personalize therapy (e.g., identifying ‘shunters’, non-adherence). We evaluated practice patterns pertaining to SLE women with LN in preconception and gestational periods, focusing on pharmacogenetic testing and drug monitoring. Methods In 02/2022, we distributed an electronic survey to 39 Systemic Lupus International Collaborating Clinics (SLICC) members. Physicians were queried about number of LN patients seen for pregnancy planning, wait time physicians recommend preconception after renal response, choice of pregnancy-compatible immunosuppressive when switching from MMF, pharmacogenetic testing before AZA initiation, and therapeutic monitoring. Results Response rate was 74%. On average, respondents saw 7.2 (standard deviation 6.6) LN patients in the preceding year for pre-pregnancy counselling. Most (93%) recommended waiting for a minimal time after achieving renal response on MMF before transitioning to a pregnancy-compatible immunosuppressive (19% suggested ≤ 6 months, 44% 6–11 months, 30% 12–23 months). In patients with inactive LN for ≥ 2 years, 86% switched immunosuppressives, while 14% discontinued MMF without switching. First choice of pregnancy-compatible immunosuppressive was AZA (90%). Tacrolimus (TAC) was preferred over cyclosporine (CsA) by 96% as second option. When initiating AZA, 38% never assessed thiopurine methyltransferase (TPMT) genotype and/or phenotype and 97% never tested for nudix hydrolase 15 (NUDT15) gene. When switching MMF to AZA preconception, 14% measured 6-mercaptopurine (6-MP) levels. Most (56%) faced barriers to 6-MP testing related to access, cost, and wait times. When patients were on TAC or CsA, 48% monitored drug each trimester, while 44% never did. Conclusions There is low use of pharmacogenetic testing and therapeutic monitoring when transitioning MMF to a pregnancy-compatible drug preconception. We identified potential care gaps, which could be addressed by future pragmatic trials.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.033
Threshold uncertainty score0.066

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0020.001
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.029
GPT teacher head0.310
Teacher spread0.281 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same topicPregnancy and Medication Impact→French-language works237,207→